Introducing ZEISS arivis Pro 4.2

Your solution for advanced image analysis and visualization.

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

Fem saker du måste veta om AI 2023

Är ditt jobb hotat av maskininlärning? Varför är det viktigt att hänga med i utvecklingen inom artificiell intelligens? Här får du svar på vad du behöver veta om AI just nu.

ZEISS presents the "Quality Innovation Days"

The digital event for metrology and software.

Improved processes and more

Discover the full potential and benefits.

Fullt godkännande i EU för Calliditas njurläkemedel – "Viktig händelse"

Calliditas läkemedel Kinpeygo har fått ett fullständigt godkännande från EU-kommissionen för behandling av vuxna med njursjukdomen IgA-nefropati, IgAN.

Galenica AB

Galderma

Metabolon

Great Swedish innovations: Eye treatment became a feather in Pharmacia’s cap

From complicated and sometimes risky surgery to a routine procedure. Pharmacia’s injectable Healon revolutionised the field of eye surgery - and is considered b...

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

Vertex betalar 52 miljarder för bolag inom autoimmuna sjukdomar

Amerikanska Vertex Pharmaceuticals köper biotechbolaget Alpine Immune Sciences för 4,9 miljarder dollar, motsvarande drygt 52 miljarder kronor.

Samuel Lagercrantz: We are currently seeing medical breakthroughs in these areas

Samuel Lagercrantz, Editor in Chief of Life Science Sweden, lists three medical fields in which we are currently seeing major breakthroughs and two fields in wh...

Medicon Valley Alliance

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Don't miss ZEISS Quality Innovation Days

Digital event April 15-19, 2024.

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...

Collaboration for a simpler production of gene therapies launched

A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...

Jätteanslag till medicinsk grundforskning – åtta projekt delar på 227 miljoner

Mekanismerna bakom kronisk smärta, en atlas över tarmbarriären och B-cellsminnets outforskade dimensioner är några av de åtta grundforskningsprojekt inom medici...

Ingrid Lönnstedt: What does the p-value mean?

The smaller the better, and preferably smaller than 0.05. A p-value smaller than 5% means that the treatment effect is statistically significant at 5% significa...

Unexpected study results on testosterone – no reduction in fracture risk

Testosterone treatment is known to increase bone density and bone quality. However, a study now suggests that supplementation with the male sex hormone does not...

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...